| Literature DB >> 11180519 |
D Ramanitrahasimbola1, P Rasoanaivo, S Ratsimamanga-Urverg, E Federici, G Palazzino, C Galeffi, M Nicoletti.
Abstract
The in vivo antiplasmodial activity of voacamine was assessed in a 4-day test. It was shown to exhibit in vivo activity with 25.4% and 43.4% inhibition of parasitaemia with 2.5 and 10 mg/kg, respectively. In synchronized cultures, it was found to act on trophozoite and schizont stages of Plasmodium falciparum. Using the FMC29 strain of Plasmodium falciparum as parasite and the isobologram curve as a method to assess interaction in drug combination, it was shown to lack any chloroquine-enhancing activity and its in vitro antiplasmodial effect was not potentiated by the chemosensitizer malagashanine. Copyright -Copyright 2001 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11180519 DOI: 10.1002/1099-1573(200102)15:1<30::aid-ptr680>3.0.co;2-t
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878